chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Apathy, Asthenia, Depression, Fatigue
Clinical narrative: Today, I am in day 10 after injection and I have gradually developed high rate of heart beat; Today, I am in day 10 after injection and I have gradually developed anxiety; Today, I am in day 10 after injection and I have gradually developed depression; Today, I am in day 10 after injection and I have gradually developed lack of good sleep (insomnia); I do have still general pain in my entire body; I do have still fatigue while have no energy; I do have still lack of motivation; After injection of the first dose on March 31, I felt weak; After injection of the first dose onMarch 31, I felt fatigue; After injection of the first dose on March 31, I felt weak and fatigue with some pain on injection site that I thought is normal; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 31Mar2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021, after the first dose of vaccination patient felt weak and fatigue with some pain on injection site that I thought was normal. On 09Apr2021 after 09 days of injection patient have gradually developed high rate of heart beat, anxiety, depression and lack of good sleep (insomnia), patient have still general pain in my entire body, fatigue while have no energy and lack of motivation. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events patient felt weak and fatigue with some pain on injection site that I thought was normal, patient have gradually developed high rate of heart beat, anxiety, depression and lack of good sleep (insomnia), patient have still general pain in my entire body, fatigue while have no energy and lack of motivation was not recovered at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Insomnia, Pain, Vaccination site pain
Clinical narrative: Today, I am in day 10 after injection and I have gradually developed high rate of heart beat; Today, I am in day 10 after injection and I have gradually developed anxiety; Today, I am in day 10 after injection and I have gradually developed depression; Today, I am in day 10 after injection and I have gradually developed lack of good sleep (insomnia); I do have still general pain in my entire body; I do have still fatigue while have no energy; I do have still lack of motivation; After injection of the first dose on March 31, I felt weak; After injection of the first dose onMarch 31, I felt fatigue; After injection of the first dose on March 31, I felt weak and fatigue with some pain on injection site that I thought is normal; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 31Mar2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021, after the first dose of vaccination patient felt weak and fatigue with some pain on injection site that I thought was normal. On 09Apr2021 after 09 days of injection patient have gradually developed high rate of heart beat, anxiety, depression and lack of good sleep (insomnia), patient have still general pain in my entire body, fatigue while have no energy and lack of motivation. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events patient felt weak and fatigue with some pain on injection site that I thought was normal, patient have gradually developed high rate of heart beat, anxiety, depression and lack of good sleep (insomnia), patient have still general pain in my entire body, fatigue while have no energy and lack of motivation was not recovered at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Paronychia
Clinical narrative: Left finger has paronychia; This is a spontaneous report from a non-contactable consumer. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. Concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient's left finger had paronychia. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the adverse event which included treatment with cephalexin (MANUFACTURER UNKNOWN) prescription. The clinical outcome of the event left finger has paronychia was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Mammogram
Clinical narrative: Showed lymph nodes under both arms; Bad headaches; Chills; Very tired; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 24Mar2021 at 03:00 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus and overweight. Concomitant medications included metformin (MANUFACTURER UNKNOWN and vitamin d nos (VITAMIN D); both from an unknown for unknown indication. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 13:15, the patient experienced showed lymph nodes under both arms, bad headaches, chills and very tired. The patient reported that she had a mammogram 2D on 05Apr21. It was less than 2 weeks of vaccination and the result showed lymph nodes under both arms. Later she was informed that she should not have had done within 6 weeks of vaccine and then they explained vaccine causes lymph nodes to swell, with the vaccine everyone was showing lymph nodes who had done mammogram within 6 weeks. The patient stated that the tech did not tell her, she would have waited for 2 months if she was known. She would now wait till July because she was going to take dose 2 in April-2021. She stated that she also had a rash but she thinks they are insect bites (home had bed bugs, think red marks are bites). She further stated that she had bad headaches, chills and was very tired. On 05Apr2021, the patient underwent 2D Mammogram and the result was Showed lymph nodes under both arms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events showed lymph nodes under both arms, bad headaches, chills and very tired were not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Dysgeusia, Headache, Swelling
Clinical narrative: Headache for first one and a half days. Second full day, right under-arm painfully swollen. Persistent bitter taste on tongue.; Headache for first one and a half days. Second full day, right under-arm painfully swollen. Persistent bitter taste on tongue.; Headache for first one and a half days. Second full day, right under-arm painfully swollen. Persistent bitter taste on tongue.; Headache for first one and a half days. Second full day, right under-arm painfully swollen. Persistent bitter taste on tongue.; This is a spontaneous report from a contactable other healthcare professional. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the right arm on 08Apr2021 at 14:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to food, medicine or other products. Concomitant medications taken within two weeks prior to the vaccination included atorvastatin (MANUFACTURER UNKNOWN) from unknown date for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 06:00, the patient experienced headache for first one and a half days. Second full day on 10Apr2021, his right under-arm was painfully swollen. Patient had a persistent bitter taste on tongue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event headache for first one and a half days was resolved on 10Apr2021. The clinical outcome of the events second full day, right under-arm was painfully swollen and of persistent bitter taste on tongue was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia oral
Clinical narrative: slight numbing of mouth; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 08:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic to penicillin. Concomitant medications included colecalciferol (VITAMIN D3) from an unknown date and for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 12:00, the patient experienced slight numbing of mouth and fatigue. The patient did not receive any treatment for reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events slight numbing of mouth and fatigue were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mild soreness around the injection site that started the morning after the injection.; This is a spontaneous report received from a contactable consumer (patient).   A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 18:15 (at the age of 35-years-old) as a single dose for COVID-19 immunization. Medical history included asthma and gastroesophageal reflux disease (GERD) from unknown dates. The patient had a history of allergies to sulfa-based antibiotics from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 08:00, the patient experienced mild soreness around the injection site that started the morning after the injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of mild soreness around the injection site that started the morning after the injection was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Severe body aches in shoulder, hips, torso, and legs; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 18Feb2021 at 00:30(at the age of 66-year-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 12Mar2021 at 00:00(at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included cancer, depression and allergy to statins. Concomitant medications included IC fluphenazine (MANUFACTURER UNKNOWN) 2.5 mg, ascorbic acid, calcium, mineral nos, retinol, tocopheryl acetate, vitamin nos, vitamin b nos, zinc(CENTRUM SILVER) and colecalciferol (VITAMIN D3) 50 mcg, all from unknown dates and for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021at 00:30, the patient experienced severe body aches in shoulder, hips, torso and legs which lasted eight weeks after first dose. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient received IC Ibuprofen 800 mg three times a day as the treatment for the reported events. The clinical outcome of the event severe body aches was recovered on an unknown date in Apr2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Headache, Pyrexia
Clinical narrative: Fever of 102.8; Headache; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 at 10:15 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included the patient was allergic to a sulfa drug. The patient did not take any concomitant medications within 2 weeks prior to vaccination. The patient previously received codeine and had an allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Mar2021 at 15:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 22:30, the patient experienced a fever of 102.8, headache and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever of 102.8, headache and loss of appetite were recovered with sequelae at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Severe headache; high fever 103degrees/101 degrees; muscle/joint pain; muscle/joint pain; tired; chills; Sore arm; achy; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfur and eggs. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and ezetimibe (MANUFACTURER UNKNOWN), both for unknown indications from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN8705), via an unspecified route of administration in the left arm on 09Mar2021 at 10:00, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 12:15, the patient experienced severe headache, high fever 103degrees/101 degrees, muscle/joint pain, tired, chills, sore arm. The patient also reported that the intensity lasted two 2 days and was still tired and achy. On 30Mar2021, the patient underwent test for body temperature and the result was 103 degrees and 101 degrees. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as the result of the reported events. The clinical outcomes of the events severe headache, high fever 103degrees/101 degrees, muscle/joint pain, chills and sore arm were recovered on 01Apr2021 while the events tired and achy were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity, Pyrexia
Clinical narrative: Severe headache; high fever 103degrees/101 degrees; muscle/joint pain; muscle/joint pain; tired; chills; Sore arm; achy; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfur and eggs. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and ezetimibe (MANUFACTURER UNKNOWN), both for unknown indications from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN8705), via an unspecified route of administration in the left arm on 09Mar2021 at 10:00, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 12:15, the patient experienced severe headache, high fever 103degrees/101 degrees, muscle/joint pain, tired, chills, sore arm. The patient also reported that the intensity lasted two 2 days and was still tired and achy. On 30Mar2021, the patient underwent test for body temperature and the result was 103 degrees and 101 degrees. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as the result of the reported events. The clinical outcomes of the events severe headache, high fever 103degrees/101 degrees, muscle/joint pain, chills and sore arm were recovered on 01Apr2021 while the events tired and achy were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Lymphadenopathy, Migraine, Pyrexia
Clinical narrative: My armpit has been swollen and throbbing for the past week on the arm that I was injected.; armpit has been swollen; had a low grade fever for about four days; extreme fatigue; migraines on and off; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Er8733) via an unspecified route of administration in the right arm on 05Apr2021 at 13:15(at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, obesity and penicillin allergy. The patient did not receive any medications within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Ence202) via an unspecified route of administration in the right arm on 09Mar2021 at 13:30(at the age of 29-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 20:30, the patient's armpit was swollen and throbbing for the past week on the arm that was injected in, had a low grade fever for about four days, a week after injection had extreme fatigue and migraines on and off. The patient did not receive any treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events armpit swollen and throbbing, low grade fever, extreme fatigue and migraines was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash erythematous, Vaccination site mass, Vaccination site pain
Clinical narrative: Fourteen days after injection developed a red rash near injection site; Rash is warm and swollen; Rash is warm and swollen; Fourteen days after injection developed a red rash near injection site; Seven days after injection i had a marble size knot form at the site; Seven days after injection ihad a marble size knot form at thesite and itching lasting about a day; When vaccine was administered there was a stinging/burning sensation; mild soreness in the arm for 3-4 days after; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the arm left on 25Mar2021 at 12:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included morbid obesity. Concomitant medications included vitamin d nos (VITAMIN D) and multivitamin(manufacturer unknown) both from an unknown date for unknown indication. The patient previously took Azithromycin on an unknown date for unknown indication and experienced drug allergy. The patient previously took Flagyl on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 When vaccine was administered there was a stinging/burning sensation. In mar2021on an unknown date she had mild soreness in the arm for 3-4 days after. On 01Apr2021 at 18:00 Seven days after injection she had a marble size knot form at the site and itching lasting about a day. On 08Apr2021 Fourteen days after injection developed a red rash near injection site. Rash is warm and swollen, but not painful. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events when vaccine was administered there was a stinging/burning sensation. She had mild soreness in the arm for 3-4 days after. Seven days after injection she had a marble size knot form at the site and itching lasting about a day. Fourteen days after injection developed a red rash near injection site. Rash is warm and swollen, but not painful were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Fourteen days after injection developed a red rash near injection site; Rash is warm and swollen; Rash is warm and swollen; Fourteen days after injection developed a red rash near injection site; Seven days after injection i had a marble size knot form at the site; Seven days after injection ihad a marble size knot form at thesite and itching lasting about a day; When vaccine was administered there was a stinging/burning sensation; mild soreness in the arm for 3-4 days after; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the arm left on 25Mar2021 at 12:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included morbid obesity. Concomitant medications included vitamin d nos (VITAMIN D) and multivitamin(manufacturer unknown) both from an unknown date for unknown indication. The patient previously took Azithromycin on an unknown date for unknown indication and experienced drug allergy. The patient previously took Flagyl on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 When vaccine was administered there was a stinging/burning sensation. In mar2021on an unknown date she had mild soreness in the arm for 3-4 days after. On 01Apr2021 at 18:00 Seven days after injection she had a marble size knot form at the site and itching lasting about a day. On 08Apr2021 Fourteen days after injection developed a red rash near injection site. Rash is warm and swollen, but not painful. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events when vaccine was administered there was a stinging/burning sensation. She had mild soreness in the arm for 3-4 days after. Seven days after injection she had a marble size knot form at the site and itching lasting about a day. Fourteen days after injection developed a red rash near injection site. Rash is warm and swollen, but not painful were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fever; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8729), via an unspecified route of administration in the left arm on 03Apr2021 at 10:45 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure and hyperlipidemia. The patient did not have any allergies to medications, food or other products. Concomitant medications included metformin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), hydrochlorothiazide (HCTZ), losartan (MANUFACTURER UNKNOWN), naproxen sodium (ALEVE), Cl (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207), via an unspecified route of administration in the left arm on 13Mar2021 at 11:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 18:00, the patient experienced fever and fatigue. No therapeutic measures were taken as the result of adverse events. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever and fatigue were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: Menstrual cycle started 3 weeks early; This is a spontaneous report from a contactable nurse, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the right arm on 08Apr2021 at 10:45 (at the age of 33-year-old), as a single dose for COVID-19 immunisation. The patient had an unspecified medical history and had a history of allergies to food or medications or other products. The patient received unspecified other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 08:00, the patient experienced menstrual cycle started 3 weeks early after only 1 week of last cycle stopping. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the event menstrual cycle started 3 weeks early was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Pyrexia
Clinical narrative: Cough started 50 hours after the vaccine; Chills; Fatigue; Low-grade fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO150) via an unspecified route of administration on 07Apr2021 at 13:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 15:45, 50 hours after the vaccination, the patient experienced chills, fatigue, low-grade fever, cough and headache. The patient reported that the symptoms "pasting" over 24 hours so far at the time of reporting. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fatigue, low-grade fever, cough and headache was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Within 15 minutes of injection, a metallic taste was in my month.; This is a spontaneous report from a contactable consumer, the patient. A female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included allergy to tree nuts and chocolate. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously received bacatracin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:15, within 15 minutes of injection, the patient experienced metallic taste in mouth. It was less the next day, but was still present. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event metallic taste in mouth was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Disorientation, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: Extra tired; When started working felt extremely disoriented; Dizzy; Foggy; Feelings of super anxiety (adrenaline continued to take over); Felt a level of irritability; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 15:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took guaifenesin (MUCINEX) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021 at 10:00, the patient woke up morning with extra tired, when started working felt extremely disoriented, dizzy, foggy. It only got worsened throughout the day, feelings of super anxiety from what she could describe as adrenaline continued to take over, also felt a level of irritability she had never felt in her life. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events extra tired, when started working felt extremely disoriented, dizzy, foggy, feelings of super anxiety (adrenaline continued to take over), and felt a level of irritability were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Irritability
Clinical narrative: Extra tired; When started working felt extremely disoriented; Dizzy; Foggy; Feelings of super anxiety (adrenaline continued to take over); Felt a level of irritability; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 15:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took guaifenesin (MUCINEX) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021 at 10:00, the patient woke up morning with extra tired, when started working felt extremely disoriented, dizzy, foggy. It only got worsened throughout the day, feelings of super anxiety from what she could describe as adrenaline continued to take over, also felt a level of irritability she had never felt in her life. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events extra tired, when started working felt extremely disoriented, dizzy, foggy, feelings of super anxiety (adrenaline continued to take over), and felt a level of irritability were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, SARS-CoV-2 test, Swelling
Clinical narrative: foot swelled up intensely; this foot swelled up intensely with lots of pain.; pain shooting up in leg; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN,) via an unspecified route of administration on 05Apr2021 at 14:30 (at the age of 40-year-old), as a single dose for COVID-19 immunisation. Medical history included cadaver bone and a 3-titanium screw in the right foot from a surgery 6 years ago and the patient had a history of allergy to dairy. Concomitant medications included birth control from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 16:00, the patient experienced few hours after the vaccine foot swelled up intensely with lots of pain and had been swollen and painful ever since the injection with pain shooting up the leg. On 22Mar2021, the patient underwent COVID-19 (nasal swab) test and result was found to be negative. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events foot swelled up intensely with lots of pain and pain shooting in leg was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Bad diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 01Apr2021 at 01:45 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have a history of allergies to any food or medications or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021 at 23:00, the patient experienced bad diarrhea for 4 days. No therapeutic measures were taken for the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event bad diarrhea was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Heart rate, Heart rate increased, Malaise
Clinical narrative: Neck pain; Difficulty breathing; Fast heartbeat; Headache; Fever; Feeling unwell; Injection site swelling; Injection site redness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had history of known allergies to penicillin (MANUFACTURER UNKNOWN). Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 11:30, the patient experienced difficulty breathing, fast heartbeat, headache, neck pain, fever, feeling unwell, nausea, injection site swelling and redness. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of difficulty breathing, fast heartbeat, headache, neck pain, fever, feeling unwell, nausea, injection site swelling and redness were recovered on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Neck pain; Difficulty breathing; Fast heartbeat; Headache; Fever; Feeling unwell; Injection site swelling; Injection site redness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had history of known allergies to penicillin (MANUFACTURER UNKNOWN). Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 11:30, the patient experienced difficulty breathing, fast heartbeat, headache, neck pain, fever, feeling unwell, nausea, injection site swelling and redness. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of difficulty breathing, fast heartbeat, headache, neck pain, fever, feeling unwell, nausea, injection site swelling and redness were recovered on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Pruritus, Vaccination site swelling
Clinical narrative: Swollen at injection site; red at injection site; itchy welt at injection site; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Er8737) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included dermatographia and sulfonamide allergy. Concomitant medications included evolcumab (REPATHA injection), rosuvastatin calcium (CRESTOR 20mg) for unknown indication from unknown date within two weeks of vaccine. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) via an unspecified route of administration in the left arm on 20Mar2021 at 11:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 09Apr2021 at 08:00, the patient experienced swollen, red and itchy welt at injection site. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swollen, red and itchy welt was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 18Mar2021 at 11:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and did not take any concomitant medication. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient experienced tinnitus. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as the result of reported event tinnitus. The clinical outcome of the event tinnitus was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.